23
Participants
Start Date
July 31, 2008
Primary Completion Date
March 31, 2011
Study Completion Date
March 31, 2011
Somatropin
Patients will be randomized at baseline in a 1:1 ratio into treatment group or control group. After six months the control group will undergo GH therapy with a higher dose of 0.067 mg/kg/day, too. All patients are treated with growth hormone for 12 months.
Somatropin
Patients will be randomized at baseline in a 1:1 ratio into treatment group or control group. After six months the control group will undergo GH therapy with a higher dose of 0.067 mg/kg/day, too. All patients are treated with growth hormone for 12 months.
Pfizer Investigational Site, Berlin
Pfizer Investigational Site, Kiel
Pfizer Investigational Site, Essen
Pfizer Investigational Site, Datteln
Pfizer Investigational Site, Cologne
Pfizer Investigational Site, Bonn
Pfizer Investigational Site, Heidelberg
Pfizer Investigational Site, München
Pfizer Investigational Site, Erlangen
Pfizer Investigational Site, Dresden
Lead Sponsor
Pfizer
INDUSTRY